27.28

3.37% 0.89

Pre-market: 27.20 -0.08 -0.29%

Schrodinger Inc (SDGR)

Overview News Price History Option Chain Financials Discussions Forecast

Schrodinger Inc stock is traded at $27.28, with a volume of 2.08M. It is up +3.37% in the last 24 hours and up +43.43% over the past month. Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Previous Close:

$26.39

Open:

$26.61

24h Volume:

2.08M

Relative Volume:

0.58

Market Cap:

$2.04B

Revenue:

$254.91M

Net Income/Loss:

$-103.48M

P/E Ratio:

-19.44

EPS:

-1.4036

Net Cash Flow:

$-148.35M

1W Performance:

-16.32%

1M Performance:

+43.43%

6M Performance:

+139.93%

1Y Performance:

+42.98%

1-Day Range:

$0.00

1-Week Range:

$25.69

$33.78

52-Week Range:

$10.95

$33.78

Schrodinger Inc Stock (SDGR) Company Profile

Name

Schrodinger Inc

Sector

Healthcare (1050)

Industry

Health Information Services (41)

Phone

503-299-1150

Address

1540 BROADWAY, NEW YORK, NY

Employee

850

Twitter

@schrodinger

Next Earnings Date

2026-11-04

Latest SEC Filings

SDGR's Discussions on Twitter

Compare SDGR vs VEEV, TEM, BTSG, HNGE, HQY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SDGR Schrodinger Inc	27.28	2.04B	254.91M	-103.48M	-148.35M	-1.4036
VEEV Veeva Systems Inc	296.13	47.95B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	70.93	12.88B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	63.74	12.61B	13.65B	169.86M	412.12M	1.0758
HNGE Hinge Health Inc	102.90	8.30B	646.34M	-512.40M	202.76M	-6.6871
HQY Healthequity Inc	92.61	7.66B	1.34B	230.70M	440.96M	2.6695

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-14-26	Resumed	UBS	Neutral
Dec-15-25	Upgrade	BofA Securities	Neutral → Buy
Sep-30-25	Initiated	Goldman	Neutral
Aug-15-25	Downgrade	Citigroup	Buy → Neutral
Aug-14-25	Initiated	Barclays	Overweight
Jul-03-25	Resumed	Morgan Stanley	Equal-Weight
Jul-02-24	Initiated	Leerink Partners	Outperform
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight
May-05-23	Resumed	Piper Sandler	Overweight
Dec-19-22	Initiated	Goldman	Neutral
Mar-01-22	Initiated	Citigroup	Buy
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-19-21	Initiated	Piper Sandler	Overweight
Nov-11-21	Downgrade	BofA Securities	Buy → Neutral
Oct-13-21	Initiated	Berenberg	Buy
Sep-01-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-25-21	Initiated	Craig Hallum	Buy
Nov-23-20	Upgrade	BofA Securities	Neutral → Buy
Oct-12-20	Upgrade	Jefferies	Hold → Buy
Mar-02-20	Initiated	BMO Capital Markets	Outperform
Mar-02-20	Initiated	Jefferies	Hold
Mar-02-20	Initiated	Morgan Stanley	Equal-Weight

View All

Schrodinger Inc Stock (SDGR) Latest News

Oct 06, 2026

Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? - Zacks Investment Research

Oct 06, 2026

Oct 05, 2026

Global Drug Discovery AI Tools MarketStrategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities - GlobeNewswire Inc.

Oct 05, 2026

Sep 23, 2026

Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.

Sep 23, 2026

Sep 22, 2026

Early Warning Disclosure Regarding Common Shares of Irruptive Metals Corp. - Yahoo Finance

Sep 22, 2026

Sep 21, 2026

Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com Nigeria

Sep 21, 2026

Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com South Africa

Sep 21, 2026

Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com India

Sep 21, 2026

Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan

Sep 21, 2026

Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing - Yahoo Finance

Sep 21, 2026

Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com

Sep 21, 2026

Sep 20, 2026